title: [Strong inhibition of gastric acid secretion: when is it justifiable?].
authors.affiliation: Divisione di Gastroenterologia, Ospedale Generale Regionale, Bolzano.
authors.forename: G
authors.initials: G
authors.lastname: Dobrilla
authors.forename: S
authors.initials: S
authors.lastname: Amplaz
authors.forename: S
authors.initials: S
authors.lastname: Benvenuti
authors.forename: A
authors.initials: A
authors.lastname: Bertozzo
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D002927:Cimetidine / Q000008:administration & dosage; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D015738:Famotidine / Q000008:administration & dosage; D005744:Gastric Acid / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D009853:Omeprazole / Q000008:administration & dosage; D011899:Ranitidine / Q000008:administration & dosage; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy*
chemical_list: D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D009853:Omeprazole